Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/13/15 → 2/13/18 |
Funding
- Clinical Trial Data Services (Prot #GPX-150-002 // Prot #GPX-150-002)
- Gem Pharmaceuticals, LLC (Prot #GPX-150-002 // Prot #GPX-150-002)
Prot #GPX-150-002: Phase 2 Efficacy and Safety Study of Intravenous GPX-150, an Anthracycline Analog, in Patients with Soft Tissue Sarcoma
- Agulnik, Mark (PD/PI)
Project: Research project